Market capitalisation, EUR | 222,244.02 m |
EPS, EUR | 7.31 |
P/B ratio | 5.33 |
P/E ratio | 13.91 |
Dividend yield | 2.91% |
Revenue, EUR | 42,031.24 m |
Net income, EUR | 7,925.26 m |
Profit margin | 18.86% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.53% | Equity United States Dividend | 191 | 0.70% | 14 | +7.93% | A2PZMV | IE00BKVKW020 |
L&G Pharma Breakthrough UCITS ETF | 2.40% | Equity World Health Care Innovation | 43 | 0.49% | 17 | -2.11% | A2H9XR | IE00BF0H7608 |
YTD | +7.95% |
1 month | +0.97% |
3 months | +7.74% |
6 months | +1.49% |
1 year | +4.53% |
3 years | +28.28% |
5 years | - |
Since inception (MAX) | +21.84% |
2023 | +4.16% |
2022 | +16.57% |
2021 | - |
2020 | - |
Volatility 1 year | 16.39% |
Volatility 3 years | 18.71% |
Volatility 5 years | - |
Return per risk 1 year | 0.28 |
Return per risk 3 years | 0.46 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -12.83% |
Maximum drawdown 3 years | -14.51% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -14.67% |